(Q24791246)

English

Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study (English)

0 references

1 reference

Thomas D Gilbert

1

0 references

Daniel Smith

series ordinal

2

0 references

Daniel A Ollendorf

series ordinal

3

0 references

language of work or name

English

0 references

publication date

14 October 2004

0 references

published in

BMC Musculoskeletal Disorders

0 references

volume

5

0 references

issue

1

0 references

page(s)

36

0 references

copyright license

Creative Commons Attribution 2.0 Generic

start time

14 October 2004

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

stated in

April 2022 Public Data File from Crossref

cites work

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=526206

retrieved

7 April 2017

Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=526206

retrieved

28 September 2017

Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=526206

retrieved

28 September 2017

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=526206

retrieved

28 September 2017

The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=526206

retrieved

28 September 2017

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=526206

retrieved

30 May 2018

Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=526206

retrieved

30 May 2018

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2474-5-36

retrieved

21 January 2018

The use of infliximab in academic rheumatology practice: an audit of early clinical experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15485582

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15485582

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept and methotrexate combination therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15485582

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15485582

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of the new DMARD leflunomide: comparison to placebo and sulfasalazine in active rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15485582

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15485582

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/1471-2474-5-36

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3720151

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2474-5-36

OpenCitations bibliographic resource ID

3720151

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3720151

PubMed publication ID

15485582

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3720151

ResearchGate publication ID

8230303

0 references

(Q24791246)

Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)